MiR-1273 g-3p Promotes Malignant Progression and has Prognostic Implications in Prostate Cancer

Prostate cancer (PCa) is the most popular cancer of mankind. Our study aimed to provide the expression and the predictive significance of miR-1273 g-3p in PCa. Moreover, the effects on cell biological activities were also investigated. The relative expression of miR-1273 g-3p in PCa tissues and cell...

Full description

Saved in:
Bibliographic Details
Published inMolecular biotechnology Vol. 64; no. 1; pp. 17 - 24
Main Authors Chang, Yaxue, Deng, Qian, Guan, Zhenfeng, Cheng, Yongyi, Sun, Yi
Format Journal Article
LanguageEnglish
Published New York Springer US 01.01.2022
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Prostate cancer (PCa) is the most popular cancer of mankind. Our study aimed to provide the expression and the predictive significance of miR-1273 g-3p in PCa. Moreover, the effects on cell biological activities were also investigated. The relative expression of miR-1273 g-3p in PCa tissues and cell lines was validated by quantitative real-time PCR. Kaplan–Meier curve and Cox regression analyses were performed to indicate the prognostic value. The implications of miR-1273 g-3p on cell proliferation, migration, and invasion were validated using the CCK-8 and Transwell assay. Our results provided that the expression of miR-1273 g-3p was increased in PCa tissues and cell lines. The levels of miR-1273 g-3p were associated with Gleason score, TNM stage, clinical stage, and lymph node metastasis. Overexpression of miR-1273 g-3p indicated a promising overall survival rate. Cox regression results indicated miR-1273 g-3p might be an independent marker for PCa patients. Silenced miR-1273 g-3p inhibited PCa cell proliferation, migration, and invasion. In total, miR-1273 g-3p was increased in PCa and identified as a therapeutic target and a prognostic factor for PCa patients. Overexpression of miR-1273 g-3p might be an oncogene via accelerating cell proliferation, migration, and invasion.
AbstractList Prostate cancer (PCa) is the most popular cancer of mankind. Our study aimed to provide the expression and the predictive significance of miR-1273 g-3p in PCa. Moreover, the effects on cell biological activities were also investigated. The relative expression of miR-1273 g-3p in PCa tissues and cell lines was validated by quantitative real-time PCR. Kaplan–Meier curve and Cox regression analyses were performed to indicate the prognostic value. The implications of miR-1273 g-3p on cell proliferation, migration, and invasion were validated using the CCK-8 and Transwell assay. Our results provided that the expression of miR-1273 g-3p was increased in PCa tissues and cell lines. The levels of miR-1273 g-3p were associated with Gleason score, TNM stage, clinical stage, and lymph node metastasis. Overexpression of miR-1273 g-3p indicated a promising overall survival rate. Cox regression results indicated miR-1273 g-3p might be an independent marker for PCa patients. Silenced miR-1273 g-3p inhibited PCa cell proliferation, migration, and invasion. In total, miR-1273 g-3p was increased in PCa and identified as a therapeutic target and a prognostic factor for PCa patients. Overexpression of miR-1273 g-3p might be an oncogene via accelerating cell proliferation, migration, and invasion.
Prostate cancer (PCa) is the most popular cancer of mankind. Our study aimed to provide the expression and the predictive significance of miR-1273 g-3p in PCa. Moreover, the effects on cell biological activities were also investigated. The relative expression of miR-1273 g-3p in PCa tissues and cell lines was validated by quantitative real-time PCR. Kaplan–Meier curve and Cox regression analyses were performed to indicate the prognostic value. The implications of miR-1273 g-3p on cell proliferation, migration, and invasion were validated using the CCK-8 and Transwell assay. Our results provided that the expression of miR-1273 g-3p was increased in PCa tissues and cell lines. The levels of miR-1273 g-3p were associated with Gleason score, TNM stage, clinical stage, and lymph node metastasis. Overexpression of miR-1273 g-3p indicated a promising overall survival rate. Cox regression results indicated miR-1273 g-3p might be an independent marker for PCa patients. Silenced miR-1273 g-3p inhibited PCa cell proliferation, migration, and invasion. In total, miR-1273 g-3p was increased in PCa and identified as a therapeutic target and a prognostic factor for PCa patients. Overexpression of miR-1273 g-3p might be an oncogene via accelerating cell proliferation, migration, and invasion.
Prostate cancer (PCa) is the most popular cancer of mankind. Our study aimed to provide the expression and the predictive significance of miR-1273 g-3p in PCa. Moreover, the effects on cell biological activities were also investigated. The relative expression of miR-1273 g-3p in PCa tissues and cell lines was validated by quantitative real-time PCR. Kaplan-Meier curve and Cox regression analyses were performed to indicate the prognostic value. The implications of miR-1273 g-3p on cell proliferation, migration, and invasion were validated using the CCK-8 and Transwell assay. Our results provided that the expression of miR-1273 g-3p was increased in PCa tissues and cell lines. The levels of miR-1273 g-3p were associated with Gleason score, TNM stage, clinical stage, and lymph node metastasis. Overexpression of miR-1273 g-3p indicated a promising overall survival rate. Cox regression results indicated miR-1273 g-3p might be an independent marker for PCa patients. Silenced miR-1273 g-3p inhibited PCa cell proliferation, migration, and invasion. In total, miR-1273 g-3p was increased in PCa and identified as a therapeutic target and a prognostic factor for PCa patients. Overexpression of miR-1273 g-3p might be an oncogene via accelerating cell proliferation, migration, and invasion.Prostate cancer (PCa) is the most popular cancer of mankind. Our study aimed to provide the expression and the predictive significance of miR-1273 g-3p in PCa. Moreover, the effects on cell biological activities were also investigated. The relative expression of miR-1273 g-3p in PCa tissues and cell lines was validated by quantitative real-time PCR. Kaplan-Meier curve and Cox regression analyses were performed to indicate the prognostic value. The implications of miR-1273 g-3p on cell proliferation, migration, and invasion were validated using the CCK-8 and Transwell assay. Our results provided that the expression of miR-1273 g-3p was increased in PCa tissues and cell lines. The levels of miR-1273 g-3p were associated with Gleason score, TNM stage, clinical stage, and lymph node metastasis. Overexpression of miR-1273 g-3p indicated a promising overall survival rate. Cox regression results indicated miR-1273 g-3p might be an independent marker for PCa patients. Silenced miR-1273 g-3p inhibited PCa cell proliferation, migration, and invasion. In total, miR-1273 g-3p was increased in PCa and identified as a therapeutic target and a prognostic factor for PCa patients. Overexpression of miR-1273 g-3p might be an oncogene via accelerating cell proliferation, migration, and invasion.
Author Deng, Qian
Guan, Zhenfeng
Chang, Yaxue
Cheng, Yongyi
Sun, Yi
Author_xml – sequence: 1
  givenname: Yaxue
  orcidid: 0000-0001-9198-0195
  surname: Chang
  fullname: Chang, Yaxue
  email: changyxsx@163.com
  organization: Department of Urology, Shaanxi Provincial People’s Hospital
– sequence: 2
  givenname: Qian
  surname: Deng
  fullname: Deng, Qian
  organization: Department of Urology, Shaanxi Provincial People’s Hospital
– sequence: 3
  givenname: Zhenfeng
  surname: Guan
  fullname: Guan, Zhenfeng
  organization: Department of Urology, Shaanxi Provincial People’s Hospital
– sequence: 4
  givenname: Yongyi
  surname: Cheng
  fullname: Cheng, Yongyi
  organization: Department of Urology, Shaanxi Provincial People’s Hospital
– sequence: 5
  givenname: Yi
  surname: Sun
  fullname: Sun, Yi
  organization: Department of Urology, Shaanxi Provincial People’s Hospital
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34431044$$D View this record in MEDLINE/PubMed
BookMark eNqFkU1OHDEQha2IiJ-BC2SBWsqGjZPyb7uX0QgSJFAiBGvH7XYPRt3uie2R4DachZPFM0NAYkFWtqq-V2W_d4B2whQcQp8IfCEA9ddEKDCGgRIMwBTH9x_QPhGiwcBA7JQ71AxLUGIPHaR0B4UUnO2iPcY5I8D5Pvp96a8woTV7elxgtqx-xWmcskvVpRn8IpiQ16VFdCn5KVQmdNWtSZtamFL2tjofl4O3Jpd2qnxYt1I22VVzE6yLh-hjb4bkjp7PGbo5O72e_8AXP7-fz79dYMtBZcytdUoq4G0nm5qB7UjX9oICEG6MaLuuE00jGkpkq7jiDVAuekNVK1tCZM9m6GQ7dxmnPyuXsh59sm4YTHDTKmkquVJMlHn_R4XkXDVC1AX9_Aa9m1YxlI-UgaSplZQlghk6fqZW7eg6vYx-NPFB_7O5AHQL2GJOiq5_QQjodZZ6m6UuCelNlvq-iNQbkfV543OOxg_vS9lWmsqesHDx9dnvqP4CayuxbA
CitedBy_id crossref_primary_10_1016_j_biopha_2023_114392
crossref_primary_10_1016_j_cellsig_2023_110786
crossref_primary_10_3390_cancers14215418
Cites_doi 10.1101/cshperspect.a030361
10.1101/cshperspect.a030387
10.1186/s12943-017-0726-4
10.3892/ol.2019.11197
10.1007/978-3-319-95693-0_1
10.1053/j.seminoncol.2016.08.001
10.2147/ott.s92314
10.1007/s00404-018-4913-3
10.1016/j.sbi.2005.05.006
10.1590/0001-3765202020181203
10.1007/978-1-4939-8751-1_6
10.1016/j.semradonc.2016.08.002
10.2174/156801105774574658
10.3389/fphys.2018.01879
10.1186/s12894-017-0206-6
10.3389/fonc.2020.00044
10.18632/oncotarget.20427
10.3233/cbm-192399
10.1097/md.0000000000016705
10.3390/ijms20051154
10.1001/jama.2017.7248
10.1038/s41598-017-03731-8
10.1007/s12291-017-0731-9
10.1016/j.canlet.2018.07.031
10.1007/978-3-642-45195-9_3
10.1038/modpathol.2017.158
10.1042/bsr20191028
10.1080/13557858.2016.1235682
10.1002/jcb.29045
10.3322/caac.21262
ContentType Journal Article
Copyright The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021
2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021.
Copyright_xml – notice: The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021
– notice: 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
– notice: The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QL
7QO
7T7
7U9
7X7
7XB
88A
88E
88I
8AO
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABJCF
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
L6V
LK8
M0S
M1P
M2P
M7N
M7P
M7S
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PTHSS
Q9U
7X8
7S9
L.6
DOI 10.1007/s12033-021-00384-x
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Engineering Collection
ProQuest Biological Science Collection
ProQuest Health & Medical Collection
Medical Database
Science Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Engineering Database
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
Engineering Collection
ProQuest Central Basic
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
ProQuest Central Essentials
SciTech Premium Collection
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Engineering Database
Virology and AIDS Abstracts
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest Health & Medical Research Collection
ProQuest Engineering Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
ProQuest Central Basic
ProQuest Science Journals
ProQuest SciTech Collection
ProQuest Medical Library
Materials Science & Engineering Collection
ProQuest Central (Alumni)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList
ProQuest Central Student
AGRICOLA
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Engineering
Chemistry
Biology
EISSN 1559-0305
EndPage 24
ExternalDocumentID 34431044
10_1007_s12033_021_00384_x
Genre Journal Article
GrantInformation_xml – fundername: science incubation found of shaanxi provincial people’s hospital
  grantid: No. 2015YX-2
– fundername: shaanxi key research and development program
  grantid: No. 2017ZDXM-SF-050
– fundername: science incubation found of shaanxi provincial people's hospital
  grantid: No. 2015YX-2
GroupedDBID ---
-4Y
-56
-5G
-BR
-EM
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
123
1N0
2.D
203
28-
29M
2J2
2JN
2JY
2KG
2KM
2LR
2VQ
2~H
30V
3SX
3V.
4.4
406
408
40D
40E
53G
5VS
67N
6NX
7X7
88A
88E
88I
8AO
8FE
8FG
8FH
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
A8Z
AAAVM
AABHQ
AACDK
AAHBH
AAHNG
AAIAL
AAIKT
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABJCF
ABJNI
ABJOX
ABKCH
ABMNI
ABMQK
ABNWP
ABQBU
ABQSL
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACCUX
ACDTI
ACGFS
ACGOD
ACHSB
ACHXU
ACIWK
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACZOJ
ADBBV
ADHHG
ADHIR
ADINQ
ADKNI
ADKPE
ADMLS
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEUYN
AEVLU
AEXYK
AFBBN
AFEXP
AFGCZ
AFKRA
AFLOW
AFQWF
AFRAH
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHMBA
AHSBF
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AYJHY
AZFZN
AZQEC
B-.
BA0
BBNVY
BBWZM
BDATZ
BENPR
BGLVJ
BGNMA
BHPHI
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DNIVK
DPUIP
DU5
DWQXO
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNUQQ
GNWQR
GQ6
GQ7
H13
HCIFZ
HF~
HG6
HMCUK
HMJXF
HRMNR
HVGLF
HZ~
I-F
IJ-
IKXTQ
ITM
IWAJR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JZLTJ
KOV
L6V
LK8
LLZTM
M0L
M1P
M2P
M4Y
M7P
M7S
MA-
ML0
N2Q
NB0
NDZJH
NF0
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OVD
P19
P2P
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
PTHSS
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RIG
RNI
ROL
RPX
RSV
RZK
S16
S1Z
S26
S27
S28
S3A
S3B
SAP
SBL
SCG
SCLPG
SDH
SDM
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
STPWE
SV3
SZN
T13
T16
TEORI
TSG
TSV
TUC
TUS
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W48
WK6
WK8
YLTOR
Z7U
Z7V
Z7W
Z7X
Z7Y
Z82
Z87
Z8O
Z8P
Z8Q
Z8S
Z8V
Z91
ZMTXR
~EX
~KM
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7QO
7T7
7U9
7XB
8FD
8FK
ABRTQ
C1K
FR3
H94
K9.
M7N
P64
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
Q9U
7X8
7S9
L.6
ID FETCH-LOGICAL-c408t-4cce86804bd69730cd1dbf520014aa5bddd59959216b848490245fa28b6b116f3
IEDL.DBID U2A
ISSN 1073-6085
1559-0305
IngestDate Fri Jul 11 02:00:59 EDT 2025
Thu Jul 10 23:05:30 EDT 2025
Fri Jul 25 18:53:30 EDT 2025
Wed Feb 19 02:25:58 EST 2025
Thu Apr 24 23:07:52 EDT 2025
Tue Jul 01 04:11:33 EDT 2025
Fri Feb 21 02:46:43 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Prognosis
Proliferation
Prostate cancer
Migration
Invasion
miR-1273 g-3p
Language English
License 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c408t-4cce86804bd69730cd1dbf520014aa5bddd59959216b848490245fa28b6b116f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-9198-0195
PMID 34431044
PQID 2619786603
PQPubID 55363
PageCount 8
ParticipantIDs proquest_miscellaneous_2648835001
proquest_miscellaneous_2564489557
proquest_journals_2619786603
pubmed_primary_34431044
crossref_primary_10_1007_s12033_021_00384_x
crossref_citationtrail_10_1007_s12033_021_00384_x
springer_journals_10_1007_s12033_021_00384_x
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20220100
2022-01-00
2022-Jan
20220101
PublicationDateYYYYMMDD 2022-01-01
PublicationDate_xml – month: 1
  year: 2022
  text: 20220100
PublicationDecade 2020
PublicationPlace New York
PublicationPlace_xml – name: New York
– name: United States
– name: Totowa
PublicationTitle Molecular biotechnology
PublicationTitleAbbrev Mol Biotechnol
PublicationTitleAlternate Mol Biotechnol
PublicationYear 2022
Publisher Springer US
Springer Nature B.V
Publisher_xml – name: Springer US
– name: Springer Nature B.V
References Luu, Lin, Sørensen, Ogunwobi, Kumar, Chornokur, Phelan, Jones, Kidd, Batra, Yamoah, Berglund, Rounbehler, Yang, Lee, Kang, Kim, Park, Di Pietro (CR24) 2017; 17
Guo, Zeng, Li, Guo, Wang, Guo, Zhu, Wang, Zhou, Liu, Chen, Wang, Zhao, Su, Li (CR30) 2020; 92
Fang, Zhu, Hu, Khadka, Ai, Zou, Ju, Jiang, Deng, Hu (CR31) 2018; 9
Discacciati, Wolk (CR7) 2014; 202
Filipowicz, Jaskiewicz, Kolb, Pillai (CR10) 2005; 15
Günel, Gumusoglu, Dogan, Ertem, Hosseini, Cevik, Senol, Topuz, Aydinli (CR17) 2018; 298
Wu, Liu, Dong, Yang, He, Li, Zhao, Jin, Li (CR32) 2018; 435
Giri, Beebe-Dimmer (CR6) 2016; 43
Rodríguez, Bajo-Santos, Hessvik, Lorenz, Fromm, Berge, Sandvig, Linē, Llorente (CR15) 2017; 16
Waseem, Ahmad, Serajuddin, Bhaskar, Sankhwar, Mahdi (CR28) 2019; 34
Ma, Wang, Yang, Zhou, Zhou, Kong (CR19) 2019; 120
Rebbeck (CR5) 2018
Evans (CR8) 2018
Stewart, Lwaleed, Douglas, Birch (CR9) 2005; 5
Moya, Meijer, Schubert, Matin, Batra (CR13) 2019
Lee, Tang, Dorsey, Ambs (CR25) 2020
Mazza, Gioffreda, Fontana, Biagini, Carella, Palumbo, Maiello, Bazzocchi, Andriulli, Tavano (CR18) 2020; 10
Pernar, Ebot, Wilson, Mucci (CR21) 2018
Balacescu, Dumitrescu, Marian (CR27) 2018; 1856
Yang, Ji, Guo, Su, Zhao, Zhang, Liu, Qiu, Zhang, Guo, Chen (CR26) 2017; 8
Nesvadba, Cmorej, Mamova, Slowik (CR1) 2016; 65
Nabavi, Saidy, Venalainen, Haegert, Parolia, Xue, Wang, Wu, Dong, Collins, Crea, Wang (CR29) 2017; 7
CR3
Schatten (CR22) 2018; 1095
Wang, Shi, Liu, Su, Li, Dong, Zhao, Li, Wang, Jin, Huo (CR14) 2018; 23
Lu, Jia, Zhao, Shao (CR11) 2019; 25
Fu, Cao (CR23) 2015; 8
He, Mullins (CR4) 2017; 22
Bi, Zhang, Bai, Zhao, Yang (CR16) 2019; 98
Zhang, Li, Ji, Chen, Gao, Li, Qin (CR12) 2020; 19
Litwin, Tan (CR20) 2017; 317
Rebbeck (CR2) 2017; 27
O Balacescu (384_CR27) 2018; 1856
D Lee (384_CR25) 2020
AJ Evans (384_CR8) 2018
M Waseem (384_CR28) 2019; 34
HN Luu (384_CR24) 2017; 17
A Discacciati (384_CR7) 2014; 202
Y Yang (384_CR26) 2017; 8
M Nesvadba (384_CR1) 2016; 65
N Nabavi (384_CR29) 2017; 7
VN Giri (384_CR6) 2016; 43
M Rodríguez (384_CR15) 2017; 16
384_CR3
X Zhang (384_CR12) 2020; 19
C Lu (384_CR11) 2019; 25
Y Fu (384_CR23) 2015; 8
F Wu (384_CR32) 2018; 435
L Moya (384_CR13) 2019
CW Bi (384_CR16) 2019; 98
T He (384_CR4) 2017; 22
MS Litwin (384_CR20) 2017; 317
T Günel (384_CR17) 2018; 298
T Mazza (384_CR18) 2020; 10
CH Pernar (384_CR21) 2018
W Filipowicz (384_CR10) 2005; 15
H Guo (384_CR30) 2020; 92
H Ma (384_CR19) 2019; 120
TR Rebbeck (384_CR5) 2018
X Wang (384_CR14) 2018; 23
H Schatten (384_CR22) 2018; 1095
R Fang (384_CR31) 2018; 9
TR Rebbeck (384_CR2) 2017; 27
AB Stewart (384_CR9) 2005; 5
References_xml – year: 2018
  ident: CR21
  article-title: The epidemiology of prostate cancer
  publication-title: Cold Spring Harbor perspectives in medicine
  doi: 10.1101/cshperspect.a030361
– year: 2018
  ident: CR5
  article-title: Prostate cancer disparities by race and ethnicity: from nucleotide to neighborhood
  publication-title: Cold Spring Harbor perspectives in medicine
  doi: 10.1101/cshperspect.a030387
– volume: 16
  start-page: 156
  issue: 1
  year: 2017
  ident: CR15
  article-title: Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes
  publication-title: Molecular cancer
  doi: 10.1186/s12943-017-0726-4
– volume: 19
  start-page: 1530
  issue: 2
  year: 2020
  end-page: 1536
  ident: CR12
  article-title: Influence mechanism of miRNA-144 on proliferation and apoptosis of osteosarcoma cells
  publication-title: Oncology letters
  doi: 10.3892/ol.2019.11197
– volume: 1095
  start-page: 1
  year: 2018
  end-page: 14
  ident: CR22
  article-title: Brief overview of prostate cancer statistics, grading, diagnosis and treatment strategies
  publication-title: Advances in experimental medicine and biology
  doi: 10.1007/978-3-319-95693-0_1
– volume: 43
  start-page: 560
  issue: 5
  year: 2016
  end-page: 565
  ident: CR6
  article-title: Familial prostate cancer
  publication-title: Seminars in oncology
  doi: 10.1053/j.seminoncol.2016.08.001
– volume: 8
  start-page: 3827
  year: 2015
  end-page: 3835
  ident: CR23
  article-title: MicroRNA-125a-5p regulates cancer cell proliferation and migration through NAIF1 in prostate carcinoma
  publication-title: OncoTargets and therapy
  doi: 10.2147/ott.s92314
– volume: 298
  start-page: 1173
  issue: 6
  year: 2018
  end-page: 1180
  ident: CR17
  article-title: Potential biomarker of circulating hsa-miR-1273g-3p level for detection of recurrent epithelial ovarian cancer
  publication-title: Archives of gynecology and obstetrics
  doi: 10.1007/s00404-018-4913-3
– volume: 15
  start-page: 331
  issue: 3
  year: 2005
  end-page: 341
  ident: CR10
  article-title: Post-transcriptional gene silencing by siRNAs and miRNAs
  publication-title: Current opinion in structural biology
  doi: 10.1016/j.sbi.2005.05.006
– volume: 92
  issue: 1
  year: 2020
  ident: CR30
  article-title: Plasma miR-1273g-3p acts as a potential biomarker for early breast ductal cancer diagnosis
  publication-title: Anais da Academia Brasileira de Ciencias
  doi: 10.1590/0001-3765202020181203
– volume: 1856
  start-page: 103
  year: 2018
  end-page: 117
  ident: CR27
  article-title: MicroRNAs Role in Prostate Cancer
  publication-title: Methods in molecular biology (Clifton, NJ)
  doi: 10.1007/978-1-4939-8751-1_6
– volume: 27
  start-page: 3
  issue: 1
  year: 2017
  end-page: 10
  ident: CR2
  article-title: Prostate Cancer genetics: variation by race, ethnicity, and geography
  publication-title: Seminars in radiation oncology
  doi: 10.1016/j.semradonc.2016.08.002
– volume: 5
  start-page: 603
  issue: 6
  year: 2005
  end-page: 612
  ident: CR9
  article-title: Current drug therapy for prostate cancer: an overview
  publication-title: Current medicinal chemistry Anti-cancer agents
  doi: 10.2174/156801105774574658
– volume: 9
  start-page: 1879
  year: 2018
  ident: CR31
  article-title: Plasma MicroRNA pair panels as novel biomarkers for detection of early stage breast cancer
  publication-title: Frontiers in physiology
  doi: 10.3389/fphys.2018.01879
– volume: 17
  start-page: 18
  issue: 1
  year: 2017
  ident: CR24
  article-title: miRNAs associated with prostate cancer risk and progression
  publication-title: BMC urology
  doi: 10.1186/s12894-017-0206-6
– volume: 10
  start-page: 44
  year: 2020
  ident: CR18
  article-title: Clinical Significance of Circulating miR-1273g-3p and miR-122-5p in Pancreatic Cancer
  publication-title: Frontiers in oncology
  doi: 10.3389/fonc.2020.00044
– volume: 8
  start-page: 72835
  issue: 42
  year: 2017
  end-page: 72846
  ident: CR26
  article-title: The miR-486-5p plays a causative role in prostate cancer through negative regulation of multiple tumor suppressor pathways
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.20427
– ident: CR3
– volume: 25
  start-page: 115
  issue: 1
  year: 2019
  end-page: 126
  ident: CR11
  article-title: MiR-342 regulates cell proliferation and apoptosis in hepatocellular carcinoma through Wnt/β-catenin signaling pathway
  publication-title: Cancer biomarkers : Section A of Disease markers
  doi: 10.3233/cbm-192399
– volume: 98
  issue: 36
  year: 2019
  ident: CR16
  article-title: Increased expression of miR-153 predicts poor prognosis for patients with prostate cancer
  publication-title: Medicine
  doi: 10.1097/md.0000000000016705
– year: 2019
  ident: CR13
  article-title: Assessment of miR-98–5p, miR-152–3p, miR-326 and miR-4289 expression as biomarker for prostate cancer diagnosis
  publication-title: International journal of molecular sciences
  doi: 10.3390/ijms20051154
– volume: 317
  start-page: 2532
  issue: 24
  year: 2017
  end-page: 2542
  ident: CR20
  article-title: The diagnosis and treatment of prostate cancer: a review
  publication-title: JAMA
  doi: 10.1001/jama.2017.7248
– volume: 7
  start-page: 4079
  issue: 1
  year: 2017
  ident: CR29
  article-title: miR-100-5p inhibition induces apoptosis in dormant prostate cancer cells and prevents the emergence of castration-resistant prostate cancer
  publication-title: Scientific reports
  doi: 10.1038/s41598-017-03731-8
– volume: 34
  start-page: 207
  issue: 2
  year: 2019
  end-page: 212
  ident: CR28
  article-title: MicroRNA-183-5p: a new potential marker for prostate cancer
  publication-title: Indian journal of clinical biochemistry : IJCB
  doi: 10.1007/s12291-017-0731-9
– volume: 435
  start-page: 1
  year: 2018
  end-page: 9
  ident: CR32
  article-title: miR-1273g silences MAGEA3/6 to inhibit human colorectal cancer cell growth via activation of AMPK signaling
  publication-title: Cancer letters
  doi: 10.1016/j.canlet.2018.07.031
– volume: 65
  start-page: 211
  issue: 4
  year: 2016
  end-page: 214
  ident: CR1
  article-title: The incidence, mortality and risk factors of prostate cancer
  publication-title: Epidemiologie, mikrobiologie, imunologie : Casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti JE Purkyne
– volume: 202
  start-page: 27
  year: 2014
  end-page: 37
  ident: CR7
  article-title: Lifestyle and dietary factors in prostate cancer prevention
  publication-title: Recent results in cancer research Fortschritte der Krebsforschung Progres dans les recherches sur le cancer
  doi: 10.1007/978-3-642-45195-9_3
– year: 2018
  ident: CR8
  article-title: Treatment effects in prostate cancer
  publication-title: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
  doi: 10.1038/modpathol.2017.158
– volume: 23
  start-page: 444
  issue: 2
  year: 2018
  end-page: 452
  ident: CR14
  article-title: Upregulation of miR-191 promotes cell growth and invasion via targeting TIMP3 in prostate cancer
  publication-title: Journal of BUON : Official journal of the Balkan Union of Oncology
– year: 2020
  ident: CR25
  article-title: miR-484 is associated with disease recurrence and promotes migration in prostate cancer
  publication-title: Bioscience reports
  doi: 10.1042/bsr20191028
– volume: 22
  start-page: 184
  issue: 2
  year: 2017
  end-page: 195
  ident: CR4
  article-title: Age-related racial disparities in prostate cancer patients: a systematic review
  publication-title: Ethnicity & health
  doi: 10.1080/13557858.2016.1235682
– volume: 120
  start-page: 17779
  issue: 10
  year: 2019
  end-page: 17790
  ident: CR19
  article-title: Identification of reciprocal microRNA-mRNA pairs associated with metastatic potential disparities in human prostate cancer cells and signaling pathway analysis
  publication-title: Journal of cellular biochemistry
  doi: 10.1002/jcb.29045
– volume: 202
  start-page: 27
  year: 2014
  ident: 384_CR7
  publication-title: Recent results in cancer research Fortschritte der Krebsforschung Progres dans les recherches sur le cancer
  doi: 10.1007/978-3-642-45195-9_3
– volume: 98
  issue: 36
  year: 2019
  ident: 384_CR16
  publication-title: Medicine
  doi: 10.1097/md.0000000000016705
– volume: 10
  start-page: 44
  year: 2020
  ident: 384_CR18
  publication-title: Frontiers in oncology
  doi: 10.3389/fonc.2020.00044
– volume: 65
  start-page: 211
  issue: 4
  year: 2016
  ident: 384_CR1
  publication-title: Epidemiologie, mikrobiologie, imunologie : Casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti JE Purkyne
– volume: 120
  start-page: 17779
  issue: 10
  year: 2019
  ident: 384_CR19
  publication-title: Journal of cellular biochemistry
  doi: 10.1002/jcb.29045
– volume: 435
  start-page: 1
  year: 2018
  ident: 384_CR32
  publication-title: Cancer letters
  doi: 10.1016/j.canlet.2018.07.031
– volume: 27
  start-page: 3
  issue: 1
  year: 2017
  ident: 384_CR2
  publication-title: Seminars in radiation oncology
  doi: 10.1016/j.semradonc.2016.08.002
– volume: 16
  start-page: 156
  issue: 1
  year: 2017
  ident: 384_CR15
  publication-title: Molecular cancer
  doi: 10.1186/s12943-017-0726-4
– volume: 1856
  start-page: 103
  year: 2018
  ident: 384_CR27
  publication-title: Methods in molecular biology (Clifton, NJ)
  doi: 10.1007/978-1-4939-8751-1_6
– volume: 9
  start-page: 1879
  year: 2018
  ident: 384_CR31
  publication-title: Frontiers in physiology
  doi: 10.3389/fphys.2018.01879
– volume: 43
  start-page: 560
  issue: 5
  year: 2016
  ident: 384_CR6
  publication-title: Seminars in oncology
  doi: 10.1053/j.seminoncol.2016.08.001
– year: 2018
  ident: 384_CR21
  publication-title: Cold Spring Harbor perspectives in medicine
  doi: 10.1101/cshperspect.a030361
– volume: 1095
  start-page: 1
  year: 2018
  ident: 384_CR22
  publication-title: Advances in experimental medicine and biology
  doi: 10.1007/978-3-319-95693-0_1
– year: 2018
  ident: 384_CR8
  publication-title: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
  doi: 10.1038/modpathol.2017.158
– volume: 23
  start-page: 444
  issue: 2
  year: 2018
  ident: 384_CR14
  publication-title: Journal of BUON : Official journal of the Balkan Union of Oncology
– volume: 17
  start-page: 18
  issue: 1
  year: 2017
  ident: 384_CR24
  publication-title: BMC urology
  doi: 10.1186/s12894-017-0206-6
– ident: 384_CR3
  doi: 10.3322/caac.21262
– volume: 8
  start-page: 3827
  year: 2015
  ident: 384_CR23
  publication-title: OncoTargets and therapy
  doi: 10.2147/ott.s92314
– year: 2019
  ident: 384_CR13
  publication-title: International journal of molecular sciences
  doi: 10.3390/ijms20051154
– volume: 7
  start-page: 4079
  issue: 1
  year: 2017
  ident: 384_CR29
  publication-title: Scientific reports
  doi: 10.1038/s41598-017-03731-8
– volume: 22
  start-page: 184
  issue: 2
  year: 2017
  ident: 384_CR4
  publication-title: Ethnicity & health
  doi: 10.1080/13557858.2016.1235682
– volume: 15
  start-page: 331
  issue: 3
  year: 2005
  ident: 384_CR10
  publication-title: Current opinion in structural biology
  doi: 10.1016/j.sbi.2005.05.006
– year: 2020
  ident: 384_CR25
  publication-title: Bioscience reports
  doi: 10.1042/bsr20191028
– volume: 25
  start-page: 115
  issue: 1
  year: 2019
  ident: 384_CR11
  publication-title: Cancer biomarkers : Section A of Disease markers
  doi: 10.3233/cbm-192399
– volume: 92
  issue: 1
  year: 2020
  ident: 384_CR30
  publication-title: Anais da Academia Brasileira de Ciencias
  doi: 10.1590/0001-3765202020181203
– volume: 34
  start-page: 207
  issue: 2
  year: 2019
  ident: 384_CR28
  publication-title: Indian journal of clinical biochemistry : IJCB
  doi: 10.1007/s12291-017-0731-9
– volume: 317
  start-page: 2532
  issue: 24
  year: 2017
  ident: 384_CR20
  publication-title: JAMA
  doi: 10.1001/jama.2017.7248
– volume: 5
  start-page: 603
  issue: 6
  year: 2005
  ident: 384_CR9
  publication-title: Current medicinal chemistry Anti-cancer agents
  doi: 10.2174/156801105774574658
– volume: 298
  start-page: 1173
  issue: 6
  year: 2018
  ident: 384_CR17
  publication-title: Archives of gynecology and obstetrics
  doi: 10.1007/s00404-018-4913-3
– year: 2018
  ident: 384_CR5
  publication-title: Cold Spring Harbor perspectives in medicine
  doi: 10.1101/cshperspect.a030387
– volume: 19
  start-page: 1530
  issue: 2
  year: 2020
  ident: 384_CR12
  publication-title: Oncology letters
  doi: 10.3892/ol.2019.11197
– volume: 8
  start-page: 72835
  issue: 42
  year: 2017
  ident: 384_CR26
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.20427
SSID ssj0021543
Score 2.3236642
Snippet Prostate cancer (PCa) is the most popular cancer of mankind. Our study aimed to provide the expression and the predictive significance of miR-1273 g-3p in PCa....
Prostate cancer (PCa) is the most popular cancer of mankind. Our study aimed to provide the expression and the predictive significance of miR-1273 g-3p in PCa....
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 17
SubjectTerms Aged
Biochemistry
Biological effects
Biological Techniques
Biomarkers, Tumor - genetics
Biotechnology
Cell Biology
Cell growth
Cell Line, Tumor
Cell migration
Cell Movement - genetics
Cell proliferation
Cell Proliferation - genetics
Chemistry
Chemistry and Materials Science
Cholecystokinin
Human Genetics
Humans
Lymph nodes
Lymphatic Metastasis
Male
Metastases
metastasis
MicroRNAs - genetics
Middle Aged
Neoplasm Staging
oncogenes
Original Paper
Patients
Prognosis
Prostate cancer
prostatic neoplasms
Prostatic Neoplasms - genetics
Prostatic Neoplasms - mortality
Prostatic Neoplasms - pathology
Protein Science
quantitative polymerase chain reaction
Regression analysis
Survival
Survival Rate
Therapeutic targets
therapeutics
Up-Regulation
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fi9QwEB505cB7EF1Pra4SwTcvXNOmafIksnicwoqIC_tWkqbZO5DuersHd_-9M2n3hxzua5KWMDNJvmRmvgH4oKy3oUkDL7TVXFpbcoPAngeTFV7WRoVA-c6T7-piKr_Niln_4Lbqwyo3e2LcqP2ipjfyM0L6pVYqzT8t_3CqGkXe1b6ExkN4RNRlZNXlbHfhQnjQBdiXOVeILfqkmS51LqMqZhSgQM4xyW__PZjuoc17ntJ4AJ0_hSc9cmSfO1U_gwdNO4Sjrpbk3RCO95gFn0M1ufrJBYIGNuf5kv2IQXfNik0Qds8p9oWa5l0MbMts69mlXcW2dkHMzezrXqQ5u2qpK-YesTGZyfUJTM-__Bpf8L6WAq9lqtdc1nWjlU6l88rgqq698C4Q55JABRXOex-pxzKhnJZaGnLJBptpp5wQKuQvYNAu2uYVMN2YIMq8RKRn8fgvnXMixV_k3qS6liYBsRFkVfdE41Tv4ne1o0gm4Vco_CoKv7pN4OP2m2VHs3Fw9Gijn6pfcqtqZyAJvN9242IhD4htm8UNjinoOmqKojwwRuGelhcomARedrrfTimXiLdSKRM43RjDbgL_n-_rw_N9A48zSqqIDzsjGKyvb5q3CHXW7l2057_wqPa3
  priority: 102
  providerName: ProQuest
Title MiR-1273 g-3p Promotes Malignant Progression and has Prognostic Implications in Prostate Cancer
URI https://link.springer.com/article/10.1007/s12033-021-00384-x
https://www.ncbi.nlm.nih.gov/pubmed/34431044
https://www.proquest.com/docview/2619786603
https://www.proquest.com/docview/2564489557
https://www.proquest.com/docview/2648835001
Volume 64
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1baxNBFD5oi6gPRaO1qzWM4JsO7GV2Lo8xJK1KSikG4tM6s7MbC7IpTQr13_S39Jd5zl6SlmrBl12YmR2GOXP5zp7vnAPwXlpvyyIseaqt5sJaxQ0Ce16aOPUiN7Isyd95ciQPp-LLLJ21TmHLju3emSTrk3rj7BZT3jGiFJA5S3BEjtsp6u5E5JrGg7WahaCgodWrhEtEFK2rzN_7uH0d3cGYd-yj9bUzfgY7LV5kg0bAz-FBUfXgUZNB8ncPHg-7hG09eHojtuAL-DE5PeERwobrqzlPzthxzbsrlmyCyHtO9Bcqmjc02IrZyrOfdlmXVQsK3sw-3yCbs9OKqmr3IzaklXL-Eqbj0bfhIW_TKfBchHrFRZ4XWupQOC8NbuzcR96VFHYpQhmlzntfRx-LI-m00MKQVba0sXbSRZEsk13YqhZVsQdMF6aMVKIQ7FlEAMo5F4XYReJNqHNhAoi6Wc3yNtY4pbz4lW2iJJMkMpREVksiuwzgw_qbsybSxr2t9zthZe2uW2akDSotZZgE8G5djVIgI4itisUFtklJIzVpqu5pI_FYS1KcmABeNQthPaREIOQKhQjgY7cyNgP493hf_1_zN_AkJj-L-l_PPmytzi-Kt4h-Vq4PD9VM4VOPD_qwPTj4_nWE70-jo-OTfr0R_gDwQv4Q
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3dTxQxEJ8gxigPRPFrAbUm-qSN-9Htdh-MMeh5JxwxBhLeSrvtHiRk7-SOCP-Uf6Mz-3GHId4br223mUyn7a87M78BeCONM6UPS54qo7gwJuM5Ante5nHqRJHLsqR85-G-7B-K70fp0Qr86XJhKKyyOxPrg9qNC_pH_oGQfqakDJNPk1-cqkaRd7UrodGYxa6_-o1PtunHwRdc37dx3Pt6sNPnbVUBXohQzbgoCq-kCoV1Mkf7LlzkbEnsQxGKmlrnXE3CFUfSKqFETs7J0sTKShtFskxw3jtwVyR4k1Nmeu_b_IGHcKQJ6M8SLhHLtEk6TapeTFXTKCCCnHGCX_57Ed5Atzc8s_WF13sI6y1SZZ8b03oEK77agHtN7cqrDVi7xmT4GPTw9CePEKSwEU8m7Ecd5OenbIgwf0SxNtQ0amJuK2Yqx07MtG6rxsQUzQbXItvZaUVdda4T2yGzPH8Ch7ei5aewWo0r_xyY8nkZZUmGyNIg3MistVGIUyQuD1Uh8gCiTpG6aInNqb7GmV5QMpPyNSpf18rXlwG8m38zaWg9lo7e7tZHt1t8qhcGGcDreTduTvK4mMqPL3BMSs_fPE2zJWMknqFJiooJ4Fmz9nOREoH4LhQigPedMSwE-L-8m8vlfQX3-wfDPb032N_dggcxJXTUP5W2YXV2fuFfIMya2Ze1bTM4vu3N9Bd3RDKo
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3dTxQxEJ_gEY08EMUPVlFrok_asB_dbvfBGAUunHiXC5GEt6Xdbk8SsndwR4R_zb-Omf24wxDvjde220ymM-1vdr4APkhttSt8x2OlFRdaJzxFYM9dGsZW5Kl0jvKd-wO5fyR-HMfHK_C3zYWhsMr2TqwuajvO6R_5NiH9REnpR9uuCYsY7na_Ts45dZAiT2vbTqMWkYPi-g-ab9MvvV08649h2N37tbPPmw4DPBe-mnGR54WSyhfGyhRlPbeBNY4qEQVIdmystVVBrjCQRgklUnJUOh0qI00QSBfhvg9gNSGrqAOr3_cGw8O5uYfgpA7vTyIuEdk0KTt14l5IPdQoPIJcc4Jf_fss3sG6d_y01fPXfQLrDW5l32pBeworRbkBD-tOltcbsHarruEzyPqnhzxAyMJGPJqwYRXyV0xZH0H_iCJvaGhUR-CWTJeW_dbTaqwcU91o1rsV585OS5qqMp_YDgnpxXM4uhc-v4BOOS6LTWCqSF2QRAniTI3gIzHGBD5uEdnUV7lIPQhaRmZ5U-acum2cZYsCzcT8DJmfVczPrjz4NP9mUhf5WLp6qz2frFH4abYQTw_ez6dRVcn_ostifIlrYjKG0zhOlqyReKNGMTLGg5f12c9JigSiPV8IDz63wrAg4P_0vlpO7zt4hIqU_ewNDl7D45CyO6o_TFvQmV1cFm8Qc83M20a4GZzctz7dAEmPODo
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=MiR-1273%C2%A0g-3p+Promotes+Malignant+Progression+and+has+Prognostic+Implications+in+Prostate+Cancer&rft.jtitle=Molecular+biotechnology&rft.au=Chang%2C+Yaxue&rft.au=Deng%2C+Qian&rft.au=Guan%2C+Zhenfeng&rft.au=Cheng%2C+Yongyi&rft.date=2022-01-01&rft.issn=1073-6085&rft.eissn=1559-0305&rft.volume=64&rft.issue=1&rft.spage=17&rft.epage=24&rft_id=info:doi/10.1007%2Fs12033-021-00384-x&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s12033_021_00384_x
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1073-6085&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1073-6085&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1073-6085&client=summon